Vanguard Capital Management filed an amended ownership statement with the SEC on October 30, 2026, disclosing beneficial ownership of 4,382,030 shares of Verastem Inc common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: Vanguard Capital Management reported holding 4,382,030 shares of Verastem Inc (NASDAQ:VSTM) common stock, representing 4.83% of the class.
  • Sole dispositive power: Vanguard Capital Management holds sole power to dispose of all 4,382,030 shares, with zero shared dispositive power reported.
  • Sole voting power: The filing reports sole voting power over 563,237 shares, with no shared voting power reported.
  • Triggering event date: The date of the event requiring the filing was September 30, 2026.
  • Amendment: This is Amendment No. 1 to a previously filed statement, signed by My Trieu-Gatt, Authorized Signatory and Head of Global Fund Administration.
  • Affiliated entities included: The filing covers securities beneficially owned by Vanguard Capital Management LLC and affiliates including Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC, and Vanguard Investments Australia Ltd.

Vanguard Capital Management's Position in Verastem Inc

According to the amended filing, Vanguard Capital Management, an investment adviser organized in Pennsylvania with principal offices at 100 Vanguard Blvd, Malvern, PA 19355, reported aggregate beneficial ownership of 4,382,030 shares of Verastem Inc common stock (CUSIP: 92337C203). The position represents 4.83% of the outstanding class, falling below the 5% threshold, which the filing addresses explicitly under Item 5, noting "Ownership of 5 percent or less of a class."

The filing notes that the reported holdings reflect securities beneficially owned by Vanguard Capital Management LLC together with several affiliates and business divisions, including Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC, and Vanguard Investments Australia Ltd, in accordance with SEC Release No. 34-39538 dated January 12, 1998. The statement specifies that securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, are included in the reported totals.

Verastem Inc, the issuer, is a biopharmaceutical company with principal executive offices located at 117 Kendrick Street, Suite 500, Needham, MA 02494. The filing certifies that the reported securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." No single other person's interest in the reported securities exceeds 5%, according to Item 6 of the filing.

What Was Disclosed

Vanguard Capital Management disclosed amended beneficial ownership of 4,382,030 Verastem Inc common shares, equal to 4.83% of the class, as of September 30, 2026. Sole dispositive power covers all reported shares; sole voting power covers 563,237 shares.